CREYON BIO

Creyon Bio is reinventing drug development from the ground up and making on-demand oligonucleotide therapeutics possible. With powerful, purpose-built data sets to drive efficient creation of machine learning models, we engineer oligonucleotide-based medicines (OBMs) for safe, precise gene-centric therapies with unprecedented speed and predictable efficacy and safety. It's a groundbreaking modular approach that slashes costs for new medicines whether treating disease impacting one patient or millions... SAN DIEGO and RESEARCH TRIANGLE PARK, NC, March 8, 2022 - Creyon Bio, Inc. ("Creyon Bio"), a drug development company engineering RNA-based medicines and their components (oligonucleotide-based medicines or OBMs) with predictable safety and efficacy profiles, launched today with the goal of making precision medicines on demand a real possibility for populations ranging from one patient to millions. Creyon Bio creates proprietary, purpose-built datasets that inform powerful machine..

Primary location: San Diego United States